Additional Volume PF-07321332 Supply Agreement for Pandemic Purposes

A Contract Award Notice
by DEPARTMENT OF HEALTH AND SOCIAL CARE

Source
Find a Tender
Type
Contract (Goods)
Duration
not specified
Value
1
Sector
HEALTH
Published
17 Jan 2022
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: London

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Vaccines have been shown to be highly effective in the fight against COVID-19, to date. However, there is a cohort of individuals who either cannot take the vaccine or for whom it is ineffective. There is therefore an urgent need to find an effective alternative. This agreement is for the procurement of 2,500,000 units of PF-07321332/ritonavir. It is one of the first oral and direct-acting antiviral drugs globally and is part of the UK’s multi-layered approach to COVID-19.

Total Quantity or Scope

Additional procurement of PF-07321332/ritonavir.

Award Detail

1 Pfizer (Kent)
  • Reference: 001373-2022-1

Award Criteria

price _

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vendors and (iii) impact fair competition between vendors.

Reference

Domains